We often seek out anti-aging skincare to diminish visible signs of growing old, however, we rarely seek out something for internal anti-aging purposes—like this innovative metabolic aging supplement by leading life sciences company Elysium Health. The new product that the brand recently debuted is titled SIGNAL™. The formula contains "a novel combination of the most direct NAD+ precursor [nicotinamide adenine dinucleotide], NMN [nicotinamide mononucleotide], and potent SIRT3 [sirtuin 3] activators." The blend targets critical metabolic factors that are lost with age—it should come as no surprise to many that metabolic efficiency slows down with age. Additionally, the metabolic aging supplement works to support the health of the mitochondrial function.
SIGNAL™ is officially the fifth consumer product that has been debuted by Elysium Health in the last seven years.
Image Credit: Elysium Health
Why This Trend Is Growing
- Metabolic Aging Supplements
- The novel combination of NMN & SIRT3 activators in SIGNAL offers innovative opportunities in the anti-aging supplement market.
- NAD+ Precursors
- SIGNAL's use of a direct NAD+ precursor, NMN, presents an opportunity for other companies to develop similar products focusing on metabolic efficiency.
- Mitochondrial Support
- The supplement's focus on supporting mitochondrial function could inspire similar products that target aging-related cellular decline.
Industries Being Reshaped
- Life Sciences
- Elysium Health's development of novel anti-aging supplements requires a strong foundation in life sciences research and development.
- Nutraceuticals
- SIGNAL offers a unique approach to anti-aging supplements, making it a potential disruptor in the nutraceuticals industry.
- Biotechnology
- Given Elysium Health's expertise in biotechnology, there is potential for further development in this sector as the company continues to innovate in the anti-aging space.
